Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 2232


The Secret Lives of Egg Donors: The Strange Hell Women Go Through to Donate Their Eggsby Colette ShadeVICE BroadlyJanuary 17th, 2016We Are Egg Donors serves as an online repository of stories about the strange hell women put themselves through to receive that lump sum.
Creativity Week: Playing God with CRISPR[cites CGS' Elliot Hosman]by Aubrey SandersBreakThru RadioJanuary 16th, 2016Elliot Hosman discusses one of the most profoundly consequential debates modern science has ever faced.
CRISPR Patent War: Billions at Stake for UC Berkeleyby Lindsey HoshawKQEDJanuary 15th, 2016Whoever gets the patent will set the terms for how the technology is used.
Plug Pulled on Cancer Clinical Trial: Sudden End for $18 Million Push by California Stem Cell Agency by David JensenCalifornia Stem Cell ReportJanuary 14th, 2016California’s ambitious effort to develop a stem cell therapy for a deadly form of skin cancer collapsed abruptly last week, apparently the victim of “excessively long development timelines."
Why Is Editas Going Public? by Pete ShanksBiopolitical TimesJanuary 14th, 2016Editas, the gene-editing company founded by several of the scientists who developed CRISPR technology, announced on January 4th that it had filed preliminary paperwork for a public offering of stock.
'Spermbots' Could Help Women Trying to Conceive (includes video)Phys.orgJanuary 13th, 2016In an attempt to improve fertility, scientists have developed motorized "spermbots" that can deliver poor swimmers—that are otherwise healthy—to an egg.
Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandaryby Andrew PollackThe New York TimesJanuary 13th, 2016Drugs for hemophilia are so lucrative, drugmakers are hiring patients and their relatives to gain an inside track and access in selling their products.
The Third Rail of the CRISPR Moonshot: Minding the Germlineby Elliot Hosman, Biopolitical TimesJanuary 13th, 2016Millions of dollars are flowing to biotech companies developing gene-editing therapies. Fortunately, most are publicly denouncing germline applications.
Take an online DNA test and you could be revealing far more than you realiseby Andelka Phillips The ConversationJanuary 12th, 2016Consumers shouldn't rely on the terms of personal genomics companies' contracts to protect their privacy or rights.
Bay Area biologist's gene-editing kit lets do-it-yourselfers play God at the kitchen tableby Lisa M. KriegerContra Costa TimesJanuary 11th, 2016"I want to democratize science," says Josiah Zaynor, who builds inexpensive CRISPR kits to encourage non-scientists to learn genome editing skills.
Displaying 11-20 of 2232  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760